Amundi cut its holdings in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 40.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 385,311 shares of the medical instruments supplier's stock after selling 258,